4-Amino-N-(thiazol-2-yl)benzenesulfonamide, 95.0%, 25g

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1S,2S)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 97%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((4-methylbenzyl)selanyl)propanoic acid, 97%, 250mg

6,7-Dihydro-5H-cyclopenta[b]pyridin-2-ol, 95.0%, 1g

4-Bromo-3-chlorobenzyl bromide, 97.0%, 1g

N-ETHYLOXETAN-3-AMINE, 95.0%, 500mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95.0%, 100mg

6-Methoxy-1-methyl-1H-indazole, 95.0%, 1g

2-(3-METHOXYPHENOXYMETHYL)OXIRANE, 95.0%, 250mg

2-aminophenol, min. 99%, for synthesis, 500 g, glass packaging

(2R)-1-BOC-4,4-DIFLUORO-2-METHYLPYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 500mg

Ethyl 4-(3-bromo-4-formylphenoxy)benzoate, 95.0%, 250mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methylglycine>98.0%(HPLC)(T)5g